Biotricity Announces Expanded R&D Team for the Development of its Fetal/Maternal and Ambulatory Wellness Monitoring Systems REDWOOD CITY, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to announce further buildout of...

Biotricity Achieves Significant Milestones for Both Fetal/Maternal and Ambulatory Wellness Monitoring Systems REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric...

Biotricity Extends Heart Rate Variability Research to Include Fetal and Maternal Applications Mobile Wireless Monitoring Solution with High Fidelity Metrics Could Make Non-Invasive Maternal/Fetal Monitoring a Reality REDWOOD CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Biotricity...